NINGBO INNO PHARMCHEM CO.,LTD. is pleased to highlight its expertise in supplying key pharmaceutical intermediates, including the high-purity compound known as [1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile. Identified by its Chemical Abstracts Service (CAS) Registry Number 1187595-85-2, this substance is a vital building block in the synthesis of Baricitinib, a widely recognized Janus kinase (JAK) inhibitor.

The importance of high-quality intermediates in the pharmaceutical industry cannot be overstated. The purity and consistency of materials like CAS 1187595-85-2 directly impact the efficacy, safety, and regulatory compliance of the final active pharmaceutical ingredient (API) and subsequent drug product. As a powder with a molecular formula of C7H10N2O2S and a molecular weight of 186.23, [1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile possesses specific chemical properties critical for its role in complex synthesis routes. Our technical specifications for this intermediate confirm a purity level typically exceeding 98%, ensuring it meets the stringent requirements of pharmaceutical manufacturing processes.

Baricitinib is an API used in the treatment of various inflammatory and autoimmune conditions, such as rheumatoid arthritis, alopecia areata, and in certain cases, COVID-19. Its mechanism of action involves inhibiting specific JAK enzymes, which are crucial components in cell signaling pathways involved in inflammation and immune response. The reliable synthesis of Baricitinib is therefore paramount to providing effective treatments to patients globally. [1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile acts as a pivotal intermediate in this synthesis, contributing the essential structural elements required to form the final Baricitinib molecule.

Our commitment at NINGBO INNO PHARMCHEM CO.,LTD. lies in providing pharmaceutical manufacturers with intermediates of the highest quality and reliability. We understand the critical nature of the supply chain in drug production and strive to be a trusted partner. The physical characteristics of [1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile, including its melting point (reported between 67-69°C), are carefully controlled and verified through rigorous analytical testing. While some properties like boiling point and density are predicted values, maintaining consistency across batches is a core aspect of our quality control protocols. These protocols are designed to ensure that every shipment of CAS 1187595-85-2 meets the required chemical identity, purity, and physical standards, facilitating smooth and predictable downstream processing for our clients.

The synthesis of complex organic molecules like pharmaceutical intermediates often involves multi-step processes requiring specialized expertise and infrastructure. Our technical team possesses significant experience in chemical synthesis, allowing us to produce [1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile efficiently while maintaining stringent quality standards. We utilize advanced analytical techniques, including chromatography and spectroscopy, to characterize the product and detect any potential impurities. This meticulous approach from raw material sourcing to final product packaging underscores our dedication to delivering excellence.

Market dynamics for pharmaceutical intermediates are influenced by the demand for the corresponding APIs. Given the established and growing therapeutic applications of Baricitinib, the demand for high-quality [1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile remains strong. Reliable access to this intermediate is essential for manufacturers to scale up production and meet global health needs. We position ourselves as a reliable supplier capable of supporting both small-scale R&D efforts and large-scale commercial manufacturing requirements.

Prospective customers looking to buy [1-(Ethylsulfonyl)Azetidin-3-Ylidene]Acetonitrile CAS 1187595-85-2 can rely on NINGBO INNO PHARMCHEM CO.,LTD. for a consistent and secure supply chain. We are a dedicated manufacturer with the capabilities to produce this intermediate to required specifications. Information regarding the current price and available quantities can be obtained by contacting our sales team directly. We welcome inquiries and are prepared to discuss your specific needs for this critical Baricitinib intermediate. Whether you need a quotation for a specific volume or information on lead times, our representatives are ready to assist. We aim to make the purchase process straightforward and transparent, providing the necessary documentation and support to ensure seamless integration into your production processes. Our commitment extends beyond simply supplying the chemical; we strive to build lasting partnerships based on quality, reliability, and mutual success in bringing essential medicines to market.